| Published Application/Species/Sample/Dilution | Reference |
|---|
- immunocytochemistry; human
| Hu Y, Zou J, Nguyen M, Chang H, Yeung J, Hao H, et al. Comparative analysis of replication and immune evasion among SARS-CoV-2 subvariants BA.2.86, JN.1, KP.2, and KP.3. MBio. 2025;16:e0350324 pubmed publisher |
- immunocytochemistry; human
| Dong D, Song Y, Wu S, Wang B, Peng C, Zhang W, et al. Molecular basis of Ad5-nCoV vaccine-induced immunogenicity. Structure. 2025;33:858-868.e5 pubmed publisher |
- immunocytochemistry; human
| Ma R, Zhang X, Li R, Dong X, Wang W, Jiang Q, et al. PLSCR1 suppresses SARS-CoV-2 infection by downregulating cell surface ACE2. J Virol. 2025;99:e0208524 pubmed publisher |
- immunocytochemistry; human
| Edeling M, Earnest L, Carrera Montoya J, Yap A, Mumford J, Roberts J, et al. Development of Methods to Produce SARS CoV-2 Virus-Like Particles at Scale. Biotechnol Bioeng. 2025;122:1118-1129 pubmed publisher |
- immunocytochemistry; human
| Tieu K, Espey M, Narayanan A, Heise R, Alem F, Conway D. SARS-CoV-2 S-protein expression drives syncytia formation in endothelial cells. Sci Rep. 2025;15:3549 pubmed publisher |
- immunocytochemistry; human
| Mendes S, Guimar xe3 es L, de Oliveira L, Costa P, da Silva N, Pereira G, et al. Intranasal liposomal remdesivir induces SARS-CoV-2 clearance in K18-hACE2 mice and ensures survival. J Control Release. 2025;379:558-573 pubmed publisher |
- immunocytochemistry; human
| Abt E, Lam A, Noguchi M, Rashid k, McLaughlin J, Teng P, et al. Staggered immunization with mRNA vaccines encoding SARS-CoV-2 polymerase or spike antigens broadens the T cell epitope repertoire. Proc Natl Acad Sci U S A. 2024;121:e2406332121 pubmed publisher |
- immunocytochemistry; human
| Mendes S, Guimar xe3 es L, Costa P, Fernandez C, Figueiredo M, Teixeira M, et al. Intranasal liposomal angiotensin-(1-7) administration reduces inflammation and viral load in the lungs during SARS-CoV-2 infection in K18-hACE2 transgenic mice. Antimicrob Agents Chemother. 2024;68:e0083524 pubmed publisher |
- immunocytochemistry; human
| Liu Y, Zhao X, Shi J, Wang Y, Liu H, Hu Y, et al. Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86/JN.1 and EG.5.1/HK.3. Nat Commun. 2024;15:8728 pubmed publisher |
- immunocytochemistry; human
| Emam M, Mahmoud M, El Guendy N, Loutfy S. Establishment of in-house assay for screening of anti-SARS-CoV-2 protein inhibitors. AMB Express. 2024;14:104 pubmed publisher |
- immunocytochemistry; human
| Deng J, Yang S, Li Y, Tan X, Liu J, Yu Y, et al. Natural evidence of coronaviral 2'-O-methyltransferase activity affecting viral pathogenesis via improved substrate RNA binding. Signal Transduct Target Ther. 2024;9:140 pubmed publisher |
- immunocytochemistry; human
| Hong W, Lei H, Peng D, Huang Y, He C, Yang J, et al. A chimeric adenovirus-vectored vaccine based on Beta spike and Delta RBD confers a broad-spectrum neutralization against Omicron-included SARS-CoV-2 variants. MedComm (2020). 2024;5:e539 pubmed publisher |
- immunocytochemistry; human
| Kim D, Kim M, Kim J, Baek K, Park H, Park S, et al. A mouse xenograft long-term replication yields a SARS-CoV-2 Delta mutant with increased lethality. J Med Virol. 2024;96:e29459 pubmed publisher |
- immunocytochemistry; human
| Guimarães L, Costa P, Scalzo J xfa nior S, Ferreira H, Braga A, de Oliveira L, et al. Nanoparticle-based DNA vaccine protects against SARS-CoV-2 variants in female preclinical models. Nat Commun. 2024;15:590 pubmed publisher |
- immunocytochemistry; human
| Kim D, Kim J, Kim M, Park H, Park S, Maharjan S, et al. Analysis of spike protein variants evolved in a novel in vivo long-term replication model for SARS-CoV-2. Front Cell Infect Microbiol. 2023;13:1280686 pubmed publisher |
- immunocytochemistry; human
| Liu L, Casner R, Guo Y, Wang Q, Iketani S, Chan J, et al. Antibodies targeting a quaternary site on SARS-CoV-2 spike glycoprotein prevent viral receptor engagement by conformational locking. Immunity. 2023;56:2442-2455.e8 pubmed publisher |
- immunocytochemistry; human
| Qu P, Xu K, Faraone J, Goodarzi N, Zheng Y, Carlin C, et al. Immune Evasion, Infectivity, and Fusogenicity of SARS-CoV-2 Omicron BA.2.86 and FLip Variants. bioRxiv. 2023;: pubmed publisher |
- immunocytochemistry; human
| Wu X, Shan K, Zan F, Tang X, Qian Z, Lu J. Optimization and Deoptimization of Codons in SARS-CoV-2 and Related Implications for Vaccine Development. Adv Sci (Weinh). 2023;10:e2205445 pubmed publisher |
- immunocytochemistry; human
| Yurkovetskiy L, Egri S, Kurhade C, Díaz Salinas M, Jaimes J, Nyalile T, et al. S:D614G and S:H655Y are gateway mutations that act epistatically to promote SARS-CoV-2 variant fitness. bioRxiv. 2023;: pubmed publisher |
- immunocytochemistry; human
| Dong W, Wang J, Tian L, Zhang J, Settles E, Qin C, et al. Factor Xa cleaves SARS-CoV-2 spike protein to block viral entry and infection. Nat Commun. 2023;14:1936 pubmed publisher |
- immunocytochemistry; human
| Chen K, Shi D, Li C, Fang Z, Guo Y, Jiang W, et al. Adenovirus Vaccine Containing Truncated SARS-CoV-2 Spike Protein S1 Subunit Leads to a Specific Immune Response in Mice. Vaccines (Basel). 2023;11: pubmed publisher |
- immunocytochemistry; human
| Qu P, Faraone J, Evans J, Zheng Y, Carlin C, Anghelina M, et al. Extraordinary Evasion of Neutralizing Antibody Response by Omicron XBB.1.5, CH.1.1 and CA.3.1 Variants. bioRxiv. 2023;: pubmed publisher |
- immunocytochemistry; human
| Seo S, Ryu E, Kim J, Shin C, Kwon O. Fluorophore-encapsulated nanobeads for on-site, rapid, and sensitive lateral flow assay. Sens Actuators B Chem. 2023;381:133364 pubmed publisher |
- immunocytochemistry; human
| Cooper A, Sidaway A, Chandrashekar A, Latta E, Chakraborty K, Yu J, et al. A genetically engineered, stem-cell-derived cellular vaccine. Cell Rep Med. 2022;3:100843 pubmed publisher |
- immunocytochemistry; human
| Frolova E, Palchevska O, Lukash T, Dominguez F, Britt W, Frolov I. Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling. J Virol. 2022;96:e0075322 pubmed publisher |
- immunocytochemistry; human
| Lubinski B, Frazier L, Phan M, Bugembe D, Cunningham J, Tang T, et al. Spike Protein Cleavage-Activation in the Context of the SARS-CoV-2 P681R Mutation: an Analysis from Its First Appearance in Lineage A.23.1 Identified in Uganda. Microbiol Spectr. 2022;10:e0151422 pubmed publisher |
- immunocytochemistry; human
| Haga K, Takai Todaka R, Sawada A, Katayama K. Luciferase-based quantification of membrane fusion induced by SARS-CoV-2 S protein. Genes Cells. 2022;27:537-543 pubmed publisher |
- immunocytochemistry; human
| Cao K, Wang X, Peng H, Ding L, Wang X, Hu Y, et al. A Single Vaccine Protects against SARS-CoV-2 and Influenza Virus in Mice. J Virol. 2022;96:e0157821 pubmed publisher |
- immunocytochemistry; human
| Zhang Y, Shang L, Zhang J, Liu Y, Jin C, Zhao Y, et al. An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity. Cell Chem Biol. 2022;29:5-18.e6 pubmed publisher |
- immunocytochemistry; human
| Shao L, Ning K, Wang J, Cheng F, Wang S, Qiu J. The large nonstructural protein (NS1) of the human bocavirus 1 (HBoV1) directly interacts with Ku70, which plays an important role in virus replication in human airway epithelia. J Virol. 2021;:JVI0184021 pubmed publisher |
- immunocytochemistry; human
| Ohtsuka J, Imai M, Fukumura M, Maeda M, Eguchi A, Ono R, et al. Non-propagative human parainfluenza virus type 2 nasal vaccine robustly protects the upper and lower airways against SARS-CoV-2. iScience. 2021;24:103379 pubmed publisher |
- immunocytochemistry; human
| Wang Q, Nair M, Anang S, Zhang S, Nguyen H, Huang Y, et al. Functional differences among the spike glycoproteins of multiple emerging severe acute respiratory syndrome coronavirus 2 variants of concern. iScience. 2021;24:103393 pubmed publisher |
- immunocytochemistry; human
| He X, Ding L, Cao K, Peng H, Gu C, Li Y, et al. A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge. Emerg Microbes Infect. 2021;10:1555-1573 pubmed publisher |
- immunocytochemistry; human
| Prahlad J, Struble L, Lutz W, Wallin S, Khurana S, Schnaubelt A, et al. CyDisCo production of functional recombinant SARS-CoV-2 spike receptor binding domain. Protein Sci. 2021;: pubmed publisher |
